Skip to main content

Identifying Innovative Technologies to Advance Pharmaceutical Manufacturing

Completed

The Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration fosters the adoption of innovative technologies by pharmaceutical companies. To assist CDER in those efforts, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will produce a consensus report that identifies emerging and upcoming technologies that have the potential to advance pharmaceutical quality and modernize pharmaceutical manufacturing for products regulated by CDER.

Meetings
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.